Keyphrases
Bloodstream Infection
100%
Carbapenem-resistant Acinetobacter Baumannii
100%
Clinical Characterization
100%
Microbiological Characterization
100%
Rifampicin
60%
Bacteremia
60%
Resistance Induction
40%
Blood Isolates
40%
Inoculum Effect
40%
Pitt Bacteremia Score
40%
Antimicrobial
20%
Multivariate Analysis
20%
Clinical Features
20%
Medical Records
20%
Confidence Interval
20%
Guro
20%
Odds Ratio
20%
Therapeutic Potential
20%
Lung
20%
Pneumonia
20%
Univariate Analysis
20%
Adult Patients
20%
Mechanical Ventilation
20%
Overall Mortality
20%
Significant Risk Factors
20%
Imipenem
20%
Critically Ill Patients
20%
High Mortality
20%
Mortality Factors
20%
High Morbidity
20%
BlaOXA
20%
Carbapenemases
20%
Tigecycline
20%
BlaOXA-23
20%
Preclinical Animal Models
20%
Empiric Antibiotics
20%
Microbiological Characteristics
20%
Rapid Progression
20%
30-day Mortality
20%
Colistin
20%
Microbiological Data
20%
Acinetobacter Infections
20%
Central Venous Catheter
20%
Prudent Antimicrobial Use
20%
Mice Pneumonia Model
20%
BlaOXA-58
20%
Medicine and Dentistry
Bloodstream Infection
100%
Acinetobacter Baumannii
100%
Carbapenem
100%
Rifampicin
37%
Multivariate Analysis
12%
Medical Record
12%
Univariate Analysis
12%
Antibiotic Therapy
12%
Antiinfective Agent
12%
Imipenem
12%
Artificial Respiration
12%
Patient with Pneumonia
12%
Tigecycline
12%
Carbapenemase
12%
Antimicrobial Therapy
12%
Central Venous Catheter
12%
Colistimethate
12%
Acinetobacter Infection
12%
Lung
12%
Odds Ratio
12%
Pharmacology, Toxicology and Pharmaceutical Science
Acinetobacter Baumannii
100%
Carbapenem
100%
Bloodstream Infection
100%
Rifampicin
37%
Antiinfective Agent
12%
Imipenem
12%
Tigecycline
12%
Carbapenemase
12%
Antibiotic Therapy
12%
Antimicrobial Therapy
12%
Colistimethate
12%
Acinetobacter Infection
12%
Experimental Mouse
12%
Immunology and Microbiology
Inoculum
100%
Acinetobacter Baumannii
100%
Medical Record
50%
Colistin
50%
Experimental Mouse
50%